AstraZeneca has turned its back on a commercially-led approach in favour of a 'science first' strategy, according to its head of drug development. Mene Pangalos, AstraZeneca's executive vice-president ...

Let’s start with the bollard. When the curators of “Pure Intention,” the 2025 iteration of Singapore Biennale, wanted to ...

Safety of A46 from Stratford to Alcester back on agenda following yet another horror crash - as landowner backs roundabout ...